Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Ampakines Attenuate Staurosporine-induced Cell Death in Primary Cortical Neurons: Implications in the 'Chemo-Brain' Phenomenon.

Radin DP, Rogers GA, Hewitt KE, Purcell R, Lippa A.

Anticancer Res. 2018 Jun;38(6):3461-3465. doi: 10.21873/anticanres.12615.

PMID:
29848697
2.

Epithelial tight junction alterations in nasal polyposis.

Rogers GA, Den Beste K, Parkos CA, Nusrat A, Delgaudio JM, Wise SK.

Int Forum Allergy Rhinol. 2011 Jan-Feb;1(1):50-4. doi: 10.1002/alr.20014.

PMID:
22287308
3.

The utility of cadaver dissection in endoscopic sinus surgery training courses.

Zuckerman JD, Wise SK, Rogers GA, Senior BA, Schlosser RJ, DelGaudio JM.

Am J Rhinol Allergy. 2009 Mar-Apr;23(2):218-24. doi: 10.2500/ajra.2009.23.3297.

PMID:
19401053
4.

Radiologic staging system for allergic fungal rhinosinusitis (AFRS).

Wise SK, Rogers GA, Ghegan MD, Harvey RJ, Delgaudio JM, Schlosser RJ.

Otolaryngol Head Neck Surg. 2009 May;140(5):735-40. doi: 10.1016/j.otohns.2008.12.053. Epub 2009 Mar 9.

PMID:
19393421
5.

Inferior meatus endoscopy and directed treatment for epiphora: early experience with a novel approach.

Rogers GA, Murchison AP, Wojno TH, DelGaudio JM.

Otolaryngol Head Neck Surg. 2009 Apr;140(4):579-84. doi: 10.1016/j.otohns.2008.12.009.

PMID:
19328350
6.

Contemporary considerations in cranial-base surgery.

Moore CE, Rogers GA.

Medscape J Med. 2008;10(12):272. Epub 2008 Dec 3. Review.

7.

Mechanisms underlying cognitive enhancement and reversal of cognitive deficits in nonhuman primates by the ampakine CX717.

Hampson RE, España RA, Rogers GA, Porrino LJ, Deadwyler SA.

Psychopharmacology (Berl). 2009 Jan;202(1-3):355-69. doi: 10.1007/s00213-008-1360-z. Epub 2008 Nov 5.

8.

Inferior meatus dacryolith: an easily managed cause of epiphora.

Rogers GA, DelGaudio JM.

Arch Otolaryngol Head Neck Surg. 2008 Oct;134(10):1110-1. doi: 10.1001/archotol.134.10.1110. No abstract available.

PMID:
18936361
9.

Restoration of long-term potentiation in middle-aged hippocampus after induction of brain-derived neurotrophic factor.

Rex CS, Lauterborn JC, Lin CY, Kramár EA, Rogers GA, Gall CM, Lynch G.

J Neurophysiol. 2006 Aug;96(2):677-85. Epub 2006 May 17.

10.

Facilitation of task performance and removal of the effects of sleep deprivation by an ampakine (CX717) in nonhuman primates.

Porrino LJ, Daunais JB, Rogers GA, Hampson RE, Deadwyler SA.

PLoS Biol. 2005 Sep;3(9):e299. Epub 2005 Aug 23.

11.

Antibody response of healthy adults to recombinant thrombospondin-related adhesive protein of cryptosporidium 1 after experimental exposure to cryptosporidium oocysts.

Okhuysen PC, Rogers GA, Crisanti A, Spano F, Huang DB, Chappell CL, Tzipori S.

Clin Diagn Lab Immunol. 2004 Mar;11(2):235-8.

12.

Magnetic resonance angiography minimizes need for arteriography after inadequate carotid duplex ultrasound scanning.

Back MR, Rogers GA, Wilson JS, Johnson BL, Shames ML, Bandyk DF.

J Vasc Surg. 2003 Sep;38(3):422-30; discussion 431.

13.

Synergistic interactions between ampakines and antipsychotic drugs.

Johnson SA, Luu NT, Herbst TA, Knapp R, Lutz D, Arai A, Rogers GA, Lynch G.

J Pharmacol Exp Ther. 1999 Apr;289(1):392-7.

PMID:
10087029
14.

Photoaffinity labeling of vesicular acetylcholine transporter from electric organ of Torpedo.

Parsons SM, Rogers GA, Gracz LM.

Methods Enzymol. 1998;296:99-116. No abstract available.

PMID:
9779443
15.

Enhancement by an ampakine of memory encoding in humans.

Ingvar M, Ambros-Ingerson J, Davis M, Granger R, Kessler M, Rogers GA, Schehr RS, Lynch G.

Exp Neurol. 1997 Aug;146(2):553-9.

PMID:
9270067
16.

Comparison of the effects of an ampakine with those of methamphetamine on aggregate neuronal activity in cortex versus striatum.

Palmer LC, Hess US, Larson J, Rogers GA, Gall CM, Lynch G.

Brain Res Mol Brain Res. 1997 Jun;46(1-2):127-35.

PMID:
9191086
17.

Double-blind study of lofexidine and clonidine in the detoxification of opiate addicts in hospital.

Kahn A, Mumford JP, Rogers GA, Beckford H.

Drug Alcohol Depend. 1997 Jan 10;44(1):57-61.

PMID:
9031821
18.

Effects of an AMPA receptor modulator on methamphetamine-induced hyperactivity in rats.

Larson J, Quach CN, LeDuc BQ, Nguyen A, Rogers GA, Lynch G.

Brain Res. 1996 Nov 4;738(2):353-6.

PMID:
8955535
19.

Effects of pharmacologically facilitating glutamatergic transmission in the trisynaptic intrahippocampal circuit.

Sirvio J, Larson J, Quach CN, Rogers GA, Lynch G.

Neuroscience. 1996 Oct;74(4):1025-35.

PMID:
8895871
20.

Facilitation of olfactory learning by a modulator of AMPA receptors.

Larson J, Lieu T, Petchpradub V, LeDuc B, Ngo H, Rogers GA, Lynch G.

J Neurosci. 1995 Dec;15(12):8023-30.

21.

18F-labelled vesamicol derivatives: syntheses and preliminary in vivo small animal positron emission tomography evaluation.

Rogers GA, Stone-Elander S, Ingvar M, Eriksson L, Parsons SM, Widén L.

Nucl Med Biol. 1994 Feb;21(2):219-30.

PMID:
9234286
22.

A drug that facilitates glutamatergic transmission reduces exploratory activity and improves performance in a learning-dependent task.

Granger R, Staubli U, Davis M, Perez Y, Nilsson L, Rogers GA, Lynch G.

Synapse. 1993 Dec;15(4):326-9.

PMID:
8153879
23.

Striatal D2/acetylcholine interactions: PET studies of the vesamicol receptor.

Ingvar M, Stone-Elander S, Rogers GA, Johansson B, Eriksson L, Parsons SM, Widén L.

Neuroreport. 1993 Sep 30;4(12):1311-4.

PMID:
8260611
24.

Kinetic and equilibrium characterization of vesamicol receptor-ligand complexes with picomolar dissociation constants.

Rogers GA, Kornreich WD, Hand K, Parsons SM.

Mol Pharmacol. 1993 Sep;44(3):633-41.

PMID:
8371715
25.

Photoaffinity labeling of the vesamicol receptor of cholinergic synaptic vesicles.

Rogers GA, Parsons SM.

Biochemistry. 1993 Aug 24;32(33):8596-601.

PMID:
8357803
26.

Acetylcholine transporter--vesamicol receptor pharmacology and structure.

Parsons SM, Bahr BA, Rogers GA, Clarkson ED, Noremberg K, Hicks BW.

Prog Brain Res. 1993;98:175-81. Review. No abstract available.

PMID:
8248506
27.

Binding and active transport of large analogues of acetylcholine by cholinergic synaptic vesicles in vitro.

Clarkson ED, Rogers GA, Parsons SM.

J Neurochem. 1992 Aug;59(2):695-700.

PMID:
1629738
28.

Linkage of the acetylcholine transporter-vesamicol receptor to proteoglycan in synaptic vesicles.

Bahr BA, Noremberg K, Rogers GA, Hicks BW, Parsons SM.

Biochemistry. 1992 Jun 30;31(25):5778-84.

PMID:
1319202
29.

Photoaffinity labeling of the acetylcholine transporter.

Rogers GA, Parsons SM.

Biochemistry. 1992 Jun 30;31(25):5770-7.

PMID:
1319201
30.

A kinetic and allosteric model for the acetylcholine transporter-vesamicol receptor in synaptic vesicles.

Bahr BA, Clarkson ED, Rogers GA, Noremberg K, Parsons SM.

Biochemistry. 1992 Jun 30;31(25):5752-62.

PMID:
1319200
31.

Positron emission tomographic studies of central cholinergic nerve terminals.

Widén L, Eriksson L, Ingvar M, Parsons SM, Rogers GA, Stone-Elander S.

Neurosci Lett. 1992 Feb 17;136(1):1-4.

PMID:
1321961
32.

Hip fractures in elderly patients taking benzodiazepines.

Rogers GA.

Am J Psychiatry. 1991 Dec;148(12):1758. No abstract available.

PMID:
1801784
33.

Rapid feasibility studies of tracers for positron emission tomography: high-resolution PET in small animals with kinetic analysis.

Ingvar M, Eriksson L, Rogers GA, Stone-Elander S, Widén L.

J Cereb Blood Flow Metab. 1991 Nov;11(6):926-31.

PMID:
1939386
35.

Persistent occultation of the vesamicol receptor.

Rogers GA, Parsons SM.

Neuroreport. 1990 Sep;1(1):22-5.

PMID:
1966599
36.

Fractional vesamicol receptor occupancy and acetylcholine active transport inhibition in synaptic vesicles.

Kaufman R, Rogers GA, Fehlmann C, Parsons SM.

Mol Pharmacol. 1989 Sep;36(3):452-8.

PMID:
2550778
37.

Inhibition of acetylcholine storage by acetylcholine analogs in vitro.

Rogers GA, Parsons SM.

Mol Pharmacol. 1989 Aug;36(2):333-41.

PMID:
2770706
38.

Synthesis, in vitro acetylcholine-storage-blocking activities, and biological properties of derivatives and analogues of trans-2-(4-phenylpiperidino)cyclohexanol (vesamicol).

Rogers GA, Parsons SM, Anderson DC, Nilsson LM, Bahr BA, Kornreich WD, Kaufman R, Jacobs RS, Kirtman B.

J Med Chem. 1989 Jun;32(6):1217-30.

PMID:
2724295
39.

Neuroleptics, prolactin, and osteoporosis.

Rogers GA, Burke GV.

Am J Psychiatry. 1987 Mar;144(3):388-9. No abstract available.

PMID:
2881495
40.

Dr. Thomas Jarram Wray (1781-1851): pioneer botanist of Augusta, Georgia.

Rogers GA, Frierson BH, Winberry CJ, Aulbach-Smith C.

Ga Hist Q. 1987;71(1):75-90. No abstract available.

PMID:
11616994
41.

Acetylcholine transport: fundamental properties and effects of pharmacologic agents.

Parsons SM, Bahr BA, Gracz LM, Kaufman R, Kornreich WD, Nilsson L, Rogers GA.

Ann N Y Acad Sci. 1987;493:220-33. No abstract available.

PMID:
3035983
42.

New issues in the care of the mentally ill.

Rogers GA.

N J Med. 1986 Jun;83(6):403-4. No abstract available.

PMID:
3461326
43.

Monitoring lithium therapy.

Rogers GA.

Psychosomatics. 1984 Mar;25(3):241-2. No abstract available.

PMID:
6709813
44.

"Circle the wagons".

Rogers GA.

J Ment Health Adm. 1983 Spring;10(1):35-8. No abstract available.

PMID:
10268718
45.

MAOIs and dietary restrictions.

Rogers GA.

J Clin Psychiatry. 1982 Nov;43(11):472. No abstract available.

PMID:
7174628
46.

Tardive-dyskinesia and lithium-associated neuropathy.

Rogers GA.

J Clin Psychiatry. 1981 Sep;42(9):363-4. No abstract available.

PMID:
6115854
47.

Flavors altered by lithium.

Rogers GA.

Am J Psychiatry. 1981 Feb;138(2):261. No abstract available.

PMID:
7457658
48.

Comments on commitment.

Rogers GA.

Am J Psychiatry. 1980 Apr;137(4):505-6. No abstract available.

PMID:
7361947
49.

Supplemental Content

Loading ...
Support Center